Arrowhead Pharmaceuticals (ARWR) EBIT (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted EBIT of -$141.3 million for Q1 2026, down 446.15% on a QoQ basis from $40.8 million in Q4 2025, and down 137.06% year-over-year from $381.2 million in Q1 2025.
Arrowhead Pharmaceuticals (ARWR) EBIT (2010 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals' EBIT history runs 17 years deep, the most recent figure standing at -$141.3 million for Q1 2026.
- Quarterly EBIT fell 137.06% year-over-year to -$141.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$221.9 million (down 87.17% YoY) and the FY2025 annual result came in at $98.3 million, up 116.36% from the prior year.
- EBIT was -$141.3 million for Q1 2026 at Arrowhead Pharmaceuticals, down from $40.8 million in the prior quarter.
- Across five years, EBIT topped out at $381.2 million in Q1 2025 and bottomed at -$176.1 million in Q2 2024.
- A 5-year average of -$54.3 million and a median of -$102.7 million in 2023 frame the typical range for EBIT.
- Annual changes were most pronounced in 2024 — EBIT plunged 362.0% — and 2025, when it soared 402.08%.
- Arrowhead Pharmaceuticals' EBIT stood at -$42.1 million in 2022, then sank by 224.07% to -$136.5 million in 2023, then decreased by 18.21% to -$161.4 million in 2024, then soared by 125.28% to $40.8 million in 2025, then slumped by 446.15% to -$141.3 million in 2026.
- Business Quant data shows ARWR's EBIT at -$141.3 million in Q1 2026, $40.8 million in Q4 2025, and $44.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Arrowhead Pharmaceuticals | 12.14 Bn | 10.36 Bn | - | -141.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -141.26 Mn |
| Dec 31, 2025 | 40.81 Mn |
| Sep 30, 2025 | 44.11 Mn |
| Jun 30, 2025 | -165.55 Mn |
| Mar 31, 2025 | 381.20 Mn |
| Dec 31, 2024 | -161.41 Mn |
| Sep 30, 2024 | -162.20 Mn |
| Jun 30, 2024 | -176.14 Mn |
| Mar 31, 2024 | -126.19 Mn |
| Dec 31, 2023 | -136.55 Mn |
| Sep 30, 2023 | -108.33 Mn |
| Jun 30, 2023 | -102.70 Mn |
| Mar 31, 2023 | 48.17 Mn |
| Dec 31, 2022 | -42.13 Mn |
| Sep 30, 2022 | -83.83 Mn |
| Jun 30, 2022 | -72.91 Mn |
| Mar 31, 2022 | 41.55 Mn |
| Dec 31, 2021 | -63.32 Mn |
| Sep 30, 2021 | -64.88 Mn |
| Jun 30, 2021 | -31.87 Mn |